Invenomic Capital Management LP lifted its holdings in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 11.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,585,707 shares of the company's stock after purchasing an additional 667,146 shares during the period. Clarivate comprises approximately 1.6% of Invenomic Capital Management LP's holdings, making the stock its 8th biggest holding. Invenomic Capital Management LP owned 0.93% of Clarivate worth $33,455,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Clarkston Capital Partners LLC lifted its holdings in shares of Clarivate by 8.1% during the 4th quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company's stock worth $359,328,000 after acquiring an additional 5,319,535 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Clarivate by 53.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock worth $141,107,000 after purchasing an additional 9,691,104 shares during the period. Thompson Siegel & Walmsley LLC boosted its holdings in shares of Clarivate by 14.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock valued at $53,333,000 after purchasing an additional 1,323,329 shares during the last quarter. Perpetual Ltd grew its stake in shares of Clarivate by 24.6% during the 4th quarter. Perpetual Ltd now owns 9,192,680 shares of the company's stock valued at $46,699,000 after buying an additional 1,816,936 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of Clarivate by 6.6% during the 4th quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company's stock valued at $44,454,000 after buying an additional 538,907 shares during the period. 85.72% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reiterated a "sector perform" rating and issued a $6.00 target price on shares of Clarivate in a report on Thursday, February 20th.
Get Our Latest Research Report on Clarivate
Clarivate Trading Down 0.1%
CLVT stock traded down $0.01 during midday trading on Friday, reaching $4.31. 4,743,278 shares of the company's stock traded hands, compared to its average volume of 5,259,780. The company has a debt-to-equity ratio of 0.88, a current ratio of 0.87 and a quick ratio of 0.88. Clarivate Plc has a fifty-two week low of $3.04 and a fifty-two week high of $7.15. The business has a 50-day moving average price of $3.88 and a two-hundred day moving average price of $4.71. The company has a market capitalization of $2.94 billion, a P/E ratio of -4.48 and a beta of 1.49.
Clarivate (NYSE:CLVT - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02. Clarivate had a negative net margin of 24.90% and a positive return on equity of 9.10%. The business had revenue of $593.70 million for the quarter, compared to analyst estimates of $574.03 million. During the same quarter in the previous year, the business posted $0.14 EPS. The business's quarterly revenue was down 4.4% on a year-over-year basis. Equities research analysts forecast that Clarivate Plc will post 0.63 EPS for the current fiscal year.
Clarivate Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Articles

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.